\-\ Texto\\:\\ \ \(0\)\
\-\ treated\\ with\\ triple\\ antibiotics\\ and\\ delivery\\ if\\ the\\ dead\\ fetus\\.\\ the\\ patient\\ recovered\\ very\\ quickly\\ after\\ the\\ delivery\\ of\\ the\\ dead\\ fetus\\.\ \(0\)\
\-\ rapid\\ development\\ of\\ airspace\\ opacity\\ in\\ the\\ bilateral\\ lungs\\ without\\ significant\\ pulmonary\\ vasculature\\ engorgement\\ or\\ pleural\\ effusions\\.\ \(0\)\
\-\ acute\\ respiratory\\ distress\\ syndrome\ \(0\)\
\-\ pulmonary\\ edema\ \(53\)\
\-\ ards\ \(90\)\
\-\ 25\\ y\\.p\\.\\ woman\\ with\\ 22wga\\ iup\\ with\\ fetal\\ demise\\ now\\ with\\ chorioamnionitis\\ and\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dead\\:\\ 0\\.19441592032753588\ \(0\)\
\-\ fetus\\:\\ 0\\.148862000820221\ \(0\)\
\-\ y\\.p\\:\\ 0\\.13157490185024623\ \(0\)\
\-\ 22wga\\:\\ 0\\.13157490185024623\ \(0\)\
\-\ chorioamnionitis\\:\\ 0\\.13157490185024623\ \(0\)\
\-\ delivery\\:\\ 0\\.13088661567531892\ \(0\)\
\-\ engorgement\\:\\ 0\\.10053846092965167\ \(0\)\
\-\ demise\\:\\ 0\\.10053846092965167\ \(0\)\
\-\ ards\\:\\ 0\\.09448674289818652\ \(0\)\
\-\ iup\\:\\ 0\\.0911562421323028\ \(0\)\
\-\ triple\\:\\ 0\\.08613426845138918\ \(0\)\
\-\ quickly\\:\\ 0\\.08613426845138918\ \(0\)\
\-\ recovered\\:\\ 0\\.07894265521418413\ \(0\)\
\-\ airspace\\:\\ 0\\.07689487728114705\ \(0\)\
\-\ pulmonary\\:\\ 0\\.07452388985731533\ \(0\)\
\-\ vasculature\\:\\ 0\\.0692706142398636\ \(0\)\
\-\ effusions\\:\\ 0\\.06509210638377597\ \(0\)\
\-\ fetal\\:\\ 0\\.06491955679570022\ \(0\)\
\-\ rapid\\:\\ 0\\.06441356348710796\ \(0\)\
\-\ opacity\\:\\ 0\\.05963040087106659\ \(0\)\
\-\ development\\:\\ 0\\.05554877945014531\ \(0\)\
\-\ distress\\:\\ 0\\.053740039796380784\ \(0\)\
\-\ shortness\\:\\ 0\\.05365914326698766\ \(0\)\
\-\ respiratory\\:\\ 0\\.05295015320751\ \(0\)\
\-\ 25\\:\\ 0\\.05155561579488168\ \(0\)\
\-\ pleural\\:\\ 0\\.04952761490557158\ \(0\)\
\-\ lungs\\:\\ 0\\.04829535220866083\ \(0\)\
\-\ antibiotics\\:\\ 0\\.047906214293589565\ \(0\)\
\-\ breath\\:\\ 0\\.047688321764915644\ \(0\)\
\-\ very\\:\\ 0\\.046295307738166105\ \(0\)\
\-\ now\\:\\ 0\\.04359874014480071\ \(0\)\
\-\ treated\\:\\ 0\\.03817687815050536\ \(0\)\
\-\ syndrome\\:\\ 0\\.03647621756320361\ \(0\)\
\-\ edema\\:\\ 0\\.03607348491688494\ \(0\)\
\-\ if\\:\\ 0\\.03460811095194978\ \(0\)\
\-\ significant\\:\\ 0\\.034296226135137664\ \(0\)\
\-\ acute\\:\\ 0\\.031490736255320825\ \(0\)\
\-\ bilateral\\:\\ 0\\.030952503422603642\ \(0\)\
\-\ without\\:\\ 0\\.030030047259077017\ \(0\)\
\-\ woman\\:\\ 0\\.02946123802222248\ \(0\)\
\-\ after\\:\\ 0\\.026388077650883617\ \(0\)\
\-\ or\\:\\ 0\\.014948100730801604\ \(0\)\
\-\ patient\\:\\ 0\\.01278495419278191\ \(0\)\
\-\ the\\:\\ 0\\.010317110798778043\ \(0\)\
\-\ with\\:\\ 0\\.006985323945665059\ \(0\)\
\-\ in\\:\\ 0\\.0062895108976157455\ \(0\)\
\-\ and\\:\\ 0\\.005373403156185626\ \(0\)\
\-\ of\\:\\ 0\\.005216588095432318\ \(0\)\
\-\ \\.\\:\\ 0\\.002649219111742259\ \(0\)\
